Form 8-K · Item 4.01 · Auditor change
Coherus Oncology, Inc.: auditor change, Ernst & Young LLP to PricewaterhouseCoopers LLP
Coherus Oncology, Inc. reported in a Form 8-K filed June 15, 2026, that on June 12, 2026, Ernst & Young LLP was dismissed as its certifying accountant, and PricewaterhouseCoopers LLP was engaged. The filing reports no disagreements with the former accountant.
In the filing's words
On June 12, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of Coherus Oncology, Inc. (the “Company”) dismissed Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm, with dismissal effective as of such date.
there were no “disagreements” (as defined in Item 304(a)(1)(iv) of Regulation S-K) with EY on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure
On June 12, 2026, the Audit Committee of the Board of Directors of the Company selected PricewaterhouseCoopers LLP (“PwC”) to be appointed to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026
Verbatim from sec.gov, Item 4.01 (Changes in Registrant's Certifying Accountant). We quote the filing; we do not characterize it.
| Company | Coherus Oncology, Inc. |
|---|---|
| Ticker | CHRS |
| Form and item | 8-K, Item 4.01 |
| Filed with the SEC | June 15, 2026 |
| What the filing states | dismissed, engaged |
| Former accountant | Ernst & Young LLP |
| New accountant | PricewaterhouseCoopers LLP |
| Date of the change | June 12, 2026 |
| Disagreements | none reported |
| Auditor's letter | Exhibit 16 on sec.gov |
| Accession number | 0001104659-26-074090 |
| SEC CIK | 0001512762 |
Coherus Oncology, Inc. reported under Form 8-K Item 4.01 (Changes in Registrant's Certifying Accountant), filed June 15, 2026. The filing's own words are quoted above.
Sources
More: all auditor changes · Something wrong? Send a correction with the primary source.